Business & regional news

Month Year

Month Year

Oct 10, 2023

Medtronic celebrates progress on social and environmental targets in 2023 Sustainability Report
- Corporate
Oct 10, 2023

Medtronic receives FDA approval for SynchroMed™ III intrathecal drug delivery system for chronic pain, cancer pain, and severe spasticity
- Neuroscience
Oct 5, 2023

Medtronic real-world evidence demonstrates consistent results of the MiniMed™ 780G regardless of demographic or cultural differences

Data shows the successful performance of the AID algorithm under substantial changes to daily routines and lifestyle, including during Ramadan.
- Diabetes
- Europe, Middle East & Africa
Oct 4, 2023

Medtronic names Paolo Di Vincenzo president of the Neuromodulation business
- Neuromodulation

Show per page